Purpuric drug eruption with leukocytoclastic vasculitis due to gefitinib

被引：11

作者：

Uchimiya, Hiroshi ^{[1
]}

Higashi, Yuko ^{[1
]}

Kawai, Kazuhiro ^{[1
]}

Kanekura, Takuro ^{[1
]}

机构：

[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Kagoshima 8908520, Japan

来源：

JOURNAL OF DERMATOLOGY | 2010年 / 37卷 / 06期

关键词：

D O I：

10.1111/j.1346-8138.2010.00896.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：562 / 564

页数：3

共 7 条

[1]

Baselga J, 2000, J CLIN ONCOL, V18, p54S

[2] Necrotizing vasculitis due to gefitinib (Iressa®) [J].

Fernandez-Guarino, Montse ;

Ryan, Ainboa Marquet ;

Perez-Garcia, Bibiana ;

Gonzalez-Lopez, Carmen ;

Olasolo, Pedro Jaen .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (08) :890-891

[3] Purpuric drug eruption possibly due to gefinitib (Iressa®) [J].

Kurokawa, I ;

Endo, K ;

Hirabayashi, M .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2005, 44 (02) :167-168

[4] Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor [J].

Lee, MW ;

Seo, CW ;

Kim, SW ;

Yang, HJ ;

Lee, HW ;

Choi, JH ;

Moon, KC ;

Koh, JK .

ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) :23-26

[5] COMPARISON OF EPIDERMAL GROWTH-FACTOR BINDING AND RECEPTOR DISTRIBUTION IN NORMAL HUMAN-EPIDERMIS AND EPIDERMAL APPENDAGES [J].

NANNEY, LB ;

MAGID, M ;

STOSCHECK, CM ;

KING, LE .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 83 (05) :385-393

[6] Severe purpuric xerotic dermatitis associated with gefitinib therapy [J].

Sheen, Yi-Shuan ;

Hsiao, Cheng-Hsiang ;

Chu, Chia-Yu .

ARCHIVES OF DERMATOLOGY, 2008, 144 (02) :269-270

[7]

UCHIHARA M, 2004, NISHI NIHON HIHU, V66, P602

← 1 →